Demonstrate Value & Win Coverage with HEOR Consulting  

Lauren Fusfeld, MBA

Senior Director, Product Commercialization

Lauren has over 15 years of consulting experience at Veranex. She supports product launches by conducting conjoint analyses, pricing assessments, and quantitative market research involving medical devices, diagnostic tools, and pharmaceuticals. She designs online surveys to provide strategic insights regarding clinical positioning, product development, and market sizing. She develops health economic models and product forecasts for a variety of conditions, including oncology. Her publications include systematic literature reviews and analyses of health economic models. Prior to joining Veranex, she conducted unmet need analyses for two pharmaceutical consulting firms: Equinox Group and MORPACE Pharma, Inc. Lauren worked on a range of indications, including cardiovascular disease, central nervous system disorders, gastrointestinal disease, metabolic disorders, infectious disease, and ophthalmologic conditions. For her pharmaceutical clients, Lauren created competitive assessments of their developmental drugs, evaluated licensing opportunities, and developed complex, dynamic models to estimate drugs’ expected sales and market shares. Before consulting for pharmaceutical companies, she worked on cost/benefit analyses as a research analyst for Industrial Economics, an environmental economics consulting firm. Lauren received her B.A. in economics and French from Amherst College and an MBA from the Johnson Graduate School of Management at Cornell University.

Dr Miyuru Amarapala MD MRCPCH MRCGP MSC

Product Commercialization Manager

As a part of the Commercial Strategy and Market Access function in Veranex, Dr Amarapala supports the team on US and global market assessment, market access strategy and value communication for medical device and diagnostic companies focusing on a wide range of clinical areas. In this role, her work includes integrated evidence planning, primary and secondary research, real-world evidence generation, manuscript development, health economic model development, and value dossier development. 

Dr Amarapala completed her MD at the University of Sydney. She trained as a Pediatrician in Great Ormond Street Hospital in London, where she gained Membership of the Royal College of Pediatrics and Child Health, gaining additional Membership of the Royal College of General Practitioners, and practiced as an NHS physician and Senior Partner while completing her Master’s in Health Economics at the University of Sheffield (ScHARR). Prior to joining Veranex, Dr. Amarapala led the Health Economics function in a US-based clinical-stage Biotech.